Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed.

Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR.

J Vasc Interv Radiol. 2011 Jul;22(7):929-34. doi: 10.1016/j.jvir.2011.02.039.

PMID:
21708319
2.

Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.

Sciarra A, Panebianco V, Salciccia S, Osimani M, Lisi D, Ciccariello M, Passariello R, Di Silverio F, Gentile V.

Eur Urol. 2008 Sep;54(3):589-600. doi: 10.1016/j.eururo.2007.12.034. Epub 2007 Dec 31.

PMID:
18226441
3.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
4.
5.

Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.

Fütterer JJ, Barentsz JO.

Eur Urol. 2008 Sep;54(3):599-600. doi: 10.1016/j.eururo.2007.12.036. Epub 2007 Dec 31. No abstract available.

PMID:
18226439
6.

The surgical learning curve for prostate cancer control after radical prostatectomy.

Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT.

J Natl Cancer Inst. 2007 Aug 1;99(15):1171-7. Epub 2007 Jul 24.

PMID:
17652279
7.

Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.

Gettman MT, Pacelli A, Slezak J, Bergstralh EJ, Blute M, Zincke H, Bostwick DG.

Urology. 1999 Sep;54(3):479-85.

PMID:
10475358
9.

Rising prostate specific antigen after radical prostatectomy: a case based review.

Nasr R, Goldenberg SL.

Can J Urol. 2001 Aug;8(4):1306-13. Review.

PMID:
11564273
10.

Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.

Leonardo C, Simone G, Papalia R, Franco G, Guaglianone S, Gallucci M.

Int J Urol. 2009 Jun;16(6):584-6. doi: 10.1111/j.1442-2042.2008.02209.x. Epub 2009 Apr 22.

11.

Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.

Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML.

J Urol. 2007 Oct;178(4 Pt 1):1311-5. Epub 2007 Aug 16.

PMID:
17698095
12.

Needle biopsy of recurrent adenocarcinoma of the prostate after radical prostatectomy.

Ripple MG, Potter SR, Partin AW, Epstein JI.

Mod Pathol. 2000 May;13(5):521-7.

13.

Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate.

Woodrum DA, Gorny KR, Mynderse LA, Amrami KK, Felmlee JP, Bjarnason H, Garcia-Medina OI, McNichols RJ, Atwell TD, Callstrom MR.

Urology. 2010 Jun;75(6):1514.e1-6. doi: 10.1016/j.urology.2010.01.059. Epub 2010 Apr 9.

PMID:
20381834
14.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
15.

Radiotherapy for locally recurrent prostate cancer.

Kirkpatrick JP, Anscher MS.

Clin Adv Hematol Oncol. 2005 Dec;3(12):933-42. Review.

PMID:
16555435
16.

[Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].

Heidenreich A, Ohlmann C, Ozgür E, Engelmann U.

Urologe A. 2006 Apr;45(4):474-81. German.

PMID:
16465521
17.
18.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
19.

Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre audit.

Winkler MH, Khan FA, Hoh IM, Okeke AA, Sugiono M, McInerney P, Boustead GB, Persad R, Kaisary AV, Gillatt DA.

BJU Int. 2004 Apr;93(6):725-9.

Supplemental Content

Support Center